Psyence Group Inc. 13D/13G Filings for Psyence Biomedical Ltd. (PBM)

Psyence Group Inc. 13D and 13G filings for Psyence Biomedical Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-05
4:30 pm
Purchase
2024-01-25 13D Psyence Biomedical Ltd.
PBM
Psyence Group Inc. 66,667
37.340%
66,667increase
(New Position)
Filing